Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Leap Therapeutics Inc | William McEvoy | Director, Chief Investment Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 5,616,907 | 5,616,907 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Khing Djien Oei | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 5,448,157 | 5,448,157 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Douglas E. Onsi | Director, CEO,CFO,Pres.,GC,Treas.&Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 2,600,000 | 2,600,000 | - | - | Restricted Stock Units | |
| CID Holdco Inc | William Tremaine Reny | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Dec 2025 | 2,497,331 | 2,470,060 | - | 0 | Common Stock | |
| Leap Therapeutics Inc | Khing Djien Oei | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Dec 2025 | 2,411,700 | 0 | - | - | Restricted Stock Units | |
| Integral Ad Science Holding Corp | Lisa Utzschneider | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Dec 2025 | 2,051,991 | 0 | - | - | Options (Right to Buy) | |
| TeraWulf Inc | Paul B. Prager | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Dec 2025 | 2,000,000 | 33,554,688 | - | - | Common stock, $0.001 par value per share | |
| Cintas | Scott D. Farmer | Director, Executive Chairman, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Dec 2025 | 1,564,766 | 953,100 (0%) | 1% | 0 | Common Stock | |
| Integral Ad Science Holding Corp | Lisa Utzschneider | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 975,238 | 0 | - | - | Market Stock Units | |
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.42 per share. | 23 Dec 2025 | 632,874 | 1,612,745 | - | 4.4 | 2,797,303 | Class A Common Stock |
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.57 per share. | 23 Dec 2025 | 632,874 | 2,245,619 | - | 4.6 | 2,892,234 | Class A Common Stock |
| TeraWulf Inc | Paul B. Prager | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Dec 2025 | 553,000 | 4,415,852 | - | - | Common stock, $0.001 par value per share | |
| Cintas | Robert E. Coletti | Director, Assistant Secretary | Other type of transaction at price $ 0.00 per share. | 23 Dec 2025 | 545,732 | 345,600 (0%) | 0% | 0 | Common Stock | |
| Integral Ad Science Holding Corp | Alpana Wegner | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 10.30 per share. | 23 Dec 2025 | 525,279 | 0 | - | 10.3 | 5,410,374 | Common Stock, $0.001 par value |
| Dermata Therapeutics Inc | Gerald T. Proehl | Director, PRESIDENT, CHAIRMAN, CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 490,196 | 490,255 | - | - | Common Stock | |
| Dermata Therapeutics Inc | Gerald T. Proehl | Director, PRESIDENT, CHAIRMAN, CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 490,196 | 490,496 | - | - | Series D Warrant (Right to Buy) | |
| Dermata Therapeutics Inc | Gerald T. Proehl | Director, PRESIDENT, CHAIRMAN, CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 490,196 | 490,496 | - | - | Series C Warrant (Right to Buy) | |
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.66 per share. | 23 Dec 2025 | 449,997 | 2,878,493 | - | 4.7 | 2,096,986 | Class A Common Stock |
| TeraWulf Inc | Paul B. Prager | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Dec 2025 | 447,000 | 491,700 | - | - | Common stock, $0.001 par value per share | |
| Clene Inc | Chidozie Ugwumba | Ten Percent Owner | 23 Dec 2025 | 424,358 | 0 | - | - | Pre-Funded Warrant to Purchase Common Stock | ||
| Clene Inc | Chidozie Ugwumba | Ten Percent Owner | 23 Dec 2025 | 424,358 | 807,495 | - | 0.0 | 424 | Common Stock | |
| Integral Ad Science Holding Corp | Lisa Utzschneider | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 10.30 per share. | 23 Dec 2025 | 411,985 | 0 | - | 10.3 | 4,243,446 | Common Stock, $0.001 par value |
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.70 per share. | 23 Dec 2025 | 402,483 | 3,328,490 | - | 4.7 | 1,891,670 | Class A Common Stock |
| Integral Ad Science Holding Corp | Lisa Utzschneider | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 367,222 | 0 | - | - | Market Stock Units | |
| Exact Sciences Corp | Kevin T. Conroy | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 330,674 | 155,417 (0%) | 0% | 0 | Common Stock | |
| Roivant Sciences Ltd | Eric Venker | President & Immunovant CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.85 per share. | 23 Dec 2025 | 313,841 | 1,811,749 | - | 3.9 | 1,208,288 | Common Shares |
| Roivant Sciences Ltd | Eric Venker | President & Immunovant CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 313,841 | 5,562,682 | - | - | Stock Option (Right to Buy) | |
| Roivant Sciences Ltd | Richard Pulik | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.85 per share. | 23 Dec 2025 | 260,000 | 646,144 | - | 3.9 | 1,001,000 | Common Shares |
| Roivant Sciences Ltd | Richard Pulik | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 260,000 | 740,000 | - | - | Stock Option (Right to Buy) | |
| Roivant Sciences Ltd | Richard Pulik | CFO | Sale of securities on an exchange or to another person at price $ 22.45 per share. | 23 Dec 2025 | 260,000 | 386,144 | - | 22.5 | 5,837,000 | Common Shares |
| FREYR Battery | Mingxing Lin | Director, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 250,000 | 0 | - | - | Restricted Stock Units (RSUs) | |
| FREYR Battery | Mingxing Lin | Director, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 250,000 | 381,800 | - | - | Common Stock | |
| Exact Sciences Corp | Kevin T. Conroy | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 244,931 | 1,101,519 (0%) | 0% | 0 | Common Stock | |
| Roivant Sciences Ltd | Eric Venker | President & Immunovant CEO | Sale of securities on an exchange or to another person at price $ 22.45 per share. | 23 Dec 2025 | 200,000 | 1,611,749 | - | 22.5 | 4,490,000 | Common Shares |
| Oracle | Jeffrey O. Henley | Director, Vice Chairman | Other type of transaction at price $ 0.00 per share. | 23 Dec 2025 | 199,071 | 1,200,910 (0%) | 0% | 0 | Common Stock | |
| Roivant Sciences Ltd | Frank M. Torti | President and Vant Chair | Grant, award, or other acquisition of securities at price $ 22.45 per share. | 23 Dec 2025 | 175,380 | 13,911,927 | - | 22.5 | 3,937,281 | Common Shares |
| Integral Ad Science Holding Corp | Lisa Utzschneider | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 157,674 | 0 | - | - | Market Stock Units | |
| Dynavax Tech Corp | Ryan Spencer | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 156,250 | 417,455 (0%) | 0% | - | Common Stock | |
| Exact Sciences Corp | Kevin T. Conroy | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. | 23 Dec 2025 | 155,417 | 1,234,970 (0%) | 0% | 101.8 | 15,824,559 | Common Stock |
| SS&C Tech Holdings Inc | William C. Stone | Director, Chairman of the Board & CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Dec 2025 | 148,000 | 32,151,302 (12%) | 0% | 0 | Common Stock | |
| Roivant Sciences Ltd | Richard Pulik | CFO | Sale of securities on an exchange or to another person at price $ 22.39 per share. | 23 Dec 2025 | 146,731 | 239,413 | - | 22.4 | 3,285,307 | Common Shares |
| Exact Sciences Corp | Kevin T. Conroy | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 138,326 | 1,124,727 (0%) | 0% | 0 | Common Stock | |
| Dynavax Tech Corp | Ryan Spencer | Director, CEO and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.38 per share. | 23 Dec 2025 | 138,168 | 379,620 (0%) | 0% | 15.4 | 2,125,024 | Common Stock |
| Integral Ad Science Holding Corp | Alexis Gil | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 10.30 per share. | 23 Dec 2025 | 136,840 | 0 | - | 10.3 | 1,409,452 | Common Stock, $0.001 par value |
| Integral Ad Science Holding Corp | Jill Putman | Director | Sale or transfer of securities back to the company at price $ 10.30 per share. | 23 Dec 2025 | 132,355 | 0 | - | 10.3 | 1,363,257 | Common Stock, $0.001 par value |
| Uber | Andrew G. Macdonald | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.52 per share. | 23 Dec 2025 | 125,000 | 339,736 (0%) | 0% | 42.5 | 5,315,000 | Common Stock |
| Uber | Andrew G. Macdonald | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 125,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Dermata Therapeutics Inc | Gerald T. Proehl | Director, PRESIDENT, CHAIRMAN, CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 122,549 | 122,563 | - | - | Common Stock | |
| Dermata Therapeutics Inc | Gerald T. Proehl | Director, PRESIDENT, CHAIRMAN, CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 122,549 | 122,549 | - | - | Series D Warrant (Right to Buy) | |
| Dermata Therapeutics Inc | Gerald T. Proehl | Director, PRESIDENT, CHAIRMAN, CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 122,549 | 122,549 | - | - | Series C Warrant (Right to Buy) | |
| Dermata Therapeutics Inc | Kyri K. Van Hoose | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 122,549 | 130,423 | - | - | Common Stock | |
| Dermata Therapeutics Inc | Kyri K. Van Hoose | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 122,549 | 122,549 | - | - | Series C Warrant (Right to Buy) | |
| Dermata Therapeutics Inc | Kyri K. Van Hoose | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 122,549 | 122,549 | - | - | Series D Warrant (Right to Buy) | |
| Roivant Sciences Ltd | Eric Venker | President & Immunovant CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.85 per share. | 23 Dec 2025 | 117,848 | 1,729,597 | - | 3.9 | 453,715 | Common Shares |
| Roivant Sciences Ltd | Eric Venker | President & Immunovant CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 117,848 | 5,444,834 | - | - | Stock Option (Right to Buy) | |
| Exact Sciences Corp | Kevin T. Conroy | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. | 23 Dec 2025 | 115,118 | 986,401 (0%) | 0% | 101.8 | 11,721,315 | Common Stock |
| Roivant Sciences Ltd | Frank M. Torti | President and Vant Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Dec 2025 | 110,489 | 13,736,547 | - | 0 | Common Shares | |
| Groupon Inc | Dusan Senkypl | Director, CEO, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Dec 2025 | 109,250 | 773,011 (0%) | 0% | 0 | Common Stock | |
| Groupon Inc | Dusan Senkypl | Director, CEO, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Dec 2025 | 109,250 | 663,761 (0%) | 0% | 0 | Common Stock | |
| Leap Therapeutics Inc | Thomas J. Dietz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 104,500 | 104,500 | - | - | Restricted Stock Units | |
| Equillium Inc | Christine Zedelmayer | Sr. Vice President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 100,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Christine Zedelmayer | Sr. Vice President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.78 per share. | 23 Dec 2025 | 100,000 | 191,444 (1%) | 0% | 0.8 | 78,500 | Common Stock |
| Equillium Inc | Christine Zedelmayer | Sr. Vice President and COO | Sale of securities on an exchange or to another person at price $ 1.50 per share. | 23 Dec 2025 | 100,000 | 91,444 (0%) | 0% | 1.5 | 150,000 | Common Stock |
| Rubrik Inc (Class A) | Arvind Nithrakashyap | Director, Chief Technology Officer | 23 Dec 2025 | 100,000 | 10,230,945 | - | - | Class B Common Stock | ||
| Rubrik Inc (Class A) | Arvind Nithrakashyap | Director, Chief Technology Officer | 23 Dec 2025 | 100,000 | 442,703 | - | 0 | Class A Common Stock | ||
| Rubrik Inc (Class A) | Arvind Nithrakashyap | Director, Chief Technology Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Dec 2025 | 100,000 | 342,703 | - | 0 | Class A Common Stock | |
| Grindr Inc (Class A) | James Fu Bin Lu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.80 per share. | 23 Dec 2025 | 100,000 | 559,455 | - | 13.8 | 1,380,000 | Common Stock |
| Leap Therapeutics Inc | Joseph Loscalzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 94,050 | 94,050 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Nissim Mashiach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 94,050 | 94,050 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | James H. Cavanaugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 94,050 | 94,050 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Christopher K. Mirabelli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 94,050 | 94,050 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | William W. Li | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 94,050 | 94,050 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Patricia Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 94,050 | 94,050 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Richard L. Schilsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 94,050 | 94,050 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Christian Richard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 94,050 | 94,050 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Khing Djien Oei | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 94,050 | 94,050 | - | - | Restricted Stock Units | |
| Skillz Inc (Class A) | Andrew Paradise | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 90,576 | 362,313 | - | - | Restricted Stock Units | |
| Skillz Inc (Class A) | Andrew Paradise | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 90,576 | 1,359,621 | - | 0 | Class A common stock | |
| Progressive | Charles A. Davis | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Dec 2025 | 87,755 | 250,222 (0%) | 0% | 0 | Common | |
| Cleanspark Inc | Thomas Leigh Wood | Director | Sale of securities on an exchange or to another person at price $ 11.69 per share. | 23 Dec 2025 | 85,315 | 41,421 (0%) | 1% | 11.7 | 997,111 | Common Stock |
| Uber | Andrew G. Macdonald | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.97 per share. | 23 Dec 2025 | 83,276 | 256,460 (0%) | 0% | 81.0 | 6,742,858 | Common Stock |
| Leap Therapeutics Inc | Thomas J. Dietz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 83,000 | 0 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Thomas J. Dietz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 83,000 | 83,000 (0%) | 0% | - | Common Stock | |
| Genuine Parts | Paul D. Donahue | Director, Non-Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Dec 2025 | 82,951 | 165,902 (0%) | 0% | 0 | Common Stock | |
| Genuine Parts | Paul D. Donahue | Director, Non-Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Dec 2025 | 82,951 | 82,951 (0%) | 0% | 0 | Common Stock | |
| Genuine Parts | Paul D. Donahue | Director, Non-Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Dec 2025 | 82,951 | 147,017 (0%) | 0% | 0 | Common Stock | |
| Genuine Parts | Paul D. Donahue | Director, Non-Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Dec 2025 | 82,951 | 64,066 (0%) | 0% | 0 | Common Stock | |
| Integral Ad Science Holding Corp | Otto Berkes | Director | Sale or transfer of securities back to the company at price $ 10.30 per share. | 23 Dec 2025 | 80,601 | 0 | - | 10.3 | 830,190 | Common Stock, $0.001 par value |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | 23 Dec 2025 | 80,279 | 185,328 (0%) | 0% | 0 | Class A Common Stock | ||
| Workday (Class A) | David A. Duffield | Ten Percent Owner | 23 Dec 2025 | 80,279 | 38,768,197 | - | - | Class B Common Stock | ||
| Dermata Therapeutics Inc | Gerald T. Proehl | Director, PRESIDENT, CHAIRMAN, CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 78,740 | 78,740 | - | - | Warrant (Right to Buy) | |
| Dermata Therapeutics Inc | Gerald T. Proehl | Director, PRESIDENT, CHAIRMAN, CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Dec 2025 | 78,740 | 0 | - | - | Warrant (Right to Buy) | |
| NewAmsterdam Pharma Co NV | Louise Kooij | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. | 23 Dec 2025 | 75,117 | 90,117 | - | 10 | 751,170 | Ordinary Shares |
| NewAmsterdam Pharma Co NV | Louise Kooij | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 75,117 | 204,898 | - | - | Option (right to buy) | |
| NewAmsterdam Pharma Co NV | Louise Kooij | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 36.21 per share. | 23 Dec 2025 | 75,117 | 15,000 | - | 36.2 | 2,719,987 | Ordinary Shares |
| Roivant Sciences Ltd | Eric Venker | President & Immunovant CEO | Sale of securities on an exchange or to another person at price $ 22.53 per share. | 23 Dec 2025 | 75,000 | 1,654,597 | - | 22.5 | 1,689,750 | Common Shares |
| GCI Liberty Inc - Ordinary Shares - Series A | John C. Malone | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 27.20 per share. | 23 Dec 2025 | 68,954 | 2,016,520 | - | 27.2 | 1,875,549 | Series C GCI Group Common Stock |
| Village Farms Intl Inc | Kathleen M. Mahoney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 65,790 | 0 | - | - | Restricted Stock | |
| Village Farms Intl Inc | Kathleen M. Mahoney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 65,790 | 116,810 (0%) | 0% | 0 | Common Shares | |
| Village Farms Intl Inc | John R. McLernon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 65,790 | 147,810 (0%) | 0% | 0 | Common Shares | |
| Village Farms Intl Inc | John R. McLernon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 65,790 | 0 | - | - | Restricted Stock | |
| Village Farms Intl Inc | Christopher Woodward | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 65,790 | 191,890 (0%) | 0% | 0 | Common Shares | |
| Village Farms Intl Inc | Christopher Woodward | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 65,790 | 0 | - | - | Restricted Stock | |
| Village Farms Intl Inc | John Henry | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 65,790 | 0 | - | - | Restricted Stock | |
| Village Farms Intl Inc | John Henry | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 65,790 | 185,310 (0%) | 0% | 0 | Common Shares | |
| Village Farms Intl Inc | David Holewinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 65,790 | 0 | - | - | Restricted Stock | |
| Village Farms Intl Inc | David Holewinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 65,790 | 204,310 (0%) | 0% | 0 | Common Shares | |
| Village Farms Intl Inc | Carolyn Hauger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 65,790 | 0 | - | - | Restricted Stock | |
| Village Farms Intl Inc | Carolyn Hauger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 65,790 | 94,810 (0%) | 0% | 0 | Common Shares | |
| Exact Sciences Corp | Kevin T. Conroy | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. | 23 Dec 2025 | 65,014 | 1,059,713 (0%) | 0% | 101.8 | 6,619,725 | Common Stock |
| Roivant Sciences Ltd | Frank M. Torti | President and Vant Chair | Other type of transaction at price $ 22.47 per share. | 23 Dec 2025 | 64,891 | 13,847,036 | - | 22.5 | 1,458,101 | Common Shares |
| Integral Ad Science Holding Corp | Bridgette P. Heller | Director | Sale or transfer of securities back to the company at price $ 10.30 per share. | 23 Dec 2025 | 62,661 | 0 | - | 10.3 | 645,408 | Common Stock, $0.001 par value |
| Dynavax Tech Corp | David Novack | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 60,625 | 70,043 (0%) | 0% | - | Common Stock | |
| Enveric Biosciences Inc | Joseph Tucker | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 60,296 | 70,355 (2%) | 1% | 0 | Common Stock | |
| Wayfair Inc (Class A) | Steven Conine | Director, Co-Founder | Sale of securities on an exchange or to another person at price $ 100.10 per share. | 23 Dec 2025 | 59,680 | 506,086 (0%) | 0% | 100.1 | 5,973,968 | Class A Common Stock |
| Wayfair Inc (Class A) | Niraj Shah | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 100.10 per share. | 23 Dec 2025 | 58,648 | 506,049 (0%) | 0% | 100.1 | 5,870,665 | Class A Common Stock |
| Wealthfront Corp | Kal Iyer | VP, Engineering | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 55,865 | 956,135 | - | - | Stock Option (Right to Buy) | |
| Wealthfront Corp | Kal Iyer | VP, Engineering | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.79 per share. | 23 Dec 2025 | 55,865 | 218,605 | - | 1.8 | 99,998 | Common Stock |
| Wealthfront Corp | Julien Wetterwald | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.79 per share. | 23 Dec 2025 | 55,865 | 623,153 | - | 1.8 | 99,998 | Common Stock |
| Wealthfront Corp | Julien Wetterwald | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 55,865 | 194,135 | - | - | Stock Option (Right to Buy) | |
| Integral Ad Science Holding Corp | Lisa Utzschneider | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 55,567 | 0 | - | - | Market Stock Units | |
| Dynavax Tech Corp | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 55,000 | 55,000 | - | - | Restricted Stock Unit | |
| Dynavax Tech Corp | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 55,000 | 472,455 (0%) | 0% | - | Common Stock | |
| Wealthfront Corp | Julien Wetterwald | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.92 per share. | 23 Dec 2025 | 52,083 | 675,236 | - | 1.9 | 99,999 | Common Stock |
| Wealthfront Corp | Julien Wetterwald | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 52,083 | 97,917 | - | - | Stock Option (Right to Buy) | |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 215.29 per share. | 23 Dec 2025 | 50,857 | 109,549 (0%) | 0% | 215.3 | 10,949,085 | Class A Common Stock |
| Energy Vault Holdings Inc | Michael Beer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.91 per share. | 23 Dec 2025 | 50,000 | 1,150,522 | - | 4.9 | 245,540 | Common Stock |
| Upexi Inc | Allan J. Marshall | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.80 per share. | 23 Dec 2025 | 50,000 | 4,046,261 | - | 1.8 | 90,000 | Common Stock |
| Datavault AI Inc | Brett A. Moyer | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 0.93 per share. | 23 Dec 2025 | 49,016 | 3,738,598 (15%) | 0% | 0.9 | 45,340 | Common Stock |
| Dynavax Tech Corp | David Novack | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.38 per share. | 23 Dec 2025 | 48,107 | 63,344 (0%) | 0% | 15.4 | 739,886 | Common Stock |
| Leslies Inc | Jason B. McDonell | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 46,449 | 46,449 | - | - | Options to purchase shares | |
| Leslies Inc | Jason B. McDonell | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 46,449 | 61,319 | - | - | Restricted Stock Units | |
| Dynavax Tech Corp | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 45,333 | 90,667 | - | - | Restricted Stock Unit | |
| Dynavax Tech Corp | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 45,333 | 517,788 (0%) | 0% | - | Common Stock | |
| Butterfly Network Inc (Class A) | Jonathan M. Rothberg | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.01 per share. | 23 Dec 2025 | 44,781 | 1,157,764 | - | 4.0 | 179,424 | Class A Common Stock |
| Grindr Inc (Class A) | James Fu Bin Lu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.51 per share. | 23 Dec 2025 | 43,994 | 515,461 | - | 13.5 | 594,359 | Common Stock |
| NewAmsterdam Pharma Co NV | Louise Kooij | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 35.30 per share. | 23 Dec 2025 | 43,872 | 15,000 | - | 35.3 | 1,548,682 | Ordinary Shares |
| Exact Sciences Corp | Jacob Orville | EVP, GM, Screening | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 42,523 | 104,490 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | Brian Baranick | EVP, GM, Precision Oncology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 42,523 | 100,859 (0%) | 0% | 0 | Common Stock | |
| Enveric Biosciences Inc | Kevin M. Coveney | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 40,198 | 47,413 (1%) | 1% | 0 | Common Stock | |
| Nano Nuclear Energy Inc | Kenny Yu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 40,000 | 5,000 | - | - | Stock Options | |
| NewAmsterdam Pharma Co NV | Louise Kooij | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 38,872 | 140,015 | - | - | Option (right to buy) | |
| NewAmsterdam Pharma Co NV | Louise Kooij | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. | 23 Dec 2025 | 38,872 | 53,872 | - | 10 | 388,720 | Ordinary Shares |
| Ascent Solar Tech Inc | Reynolds T. Forrest | Director | Sale of securities on an exchange or to another person at price $ 5.08 per share. | 23 Dec 2025 | 38,827 | 833 (0%) | 0% | 5.1 | 197,241 | Common Stock |
| Exact Sciences Corp | Aaron Bloomer | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 38,715 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp | Aaron Bloomer | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 38,715 | 52,338 (0%) | 0% | 0 | Common Stock | |
| Dynavax Tech Corp | Kelly MacDonald | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 37,500 | 66,727 (0%) | 0% | - | Common Stock | |
| Wealthfront Corp | Julien Wetterwald | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 23 Dec 2025 | 37,453 | 567,288 | - | 2.7 | 100,000 | Common Stock |
| Wealthfront Corp | Julien Wetterwald | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 37,453 | 15,047 | - | - | Stock Option (Right to Buy) | |
| Forge Global Holdings Inc (Class A) | Kelly Rodriques | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 36,800 | 441,218 | - | 0 | Common Stock, $0.0001 par value per share | |
| Dynavax Tech Corp | Kelly MacDonald | SVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.38 per share. | 23 Dec 2025 | 36,141 | 60,204 (0%) | 0% | 15.4 | 555,849 | Common Stock |
| Skillz Inc (Class A) | Andrew Paradise | Director, Chief Executive Officer, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.50 per share. | 23 Dec 2025 | 35,642 | 1,297,155 | - | 4.5 | 160,389 | Class A common stock |
| Skillz Inc (Class A) | Andrew Paradise | Director, Chief Executive Officer, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.03 per share. | 23 Dec 2025 | 35,642 | 1,404,081 | - | 5.0 | 179,279 | Class A common stock |
| Skillz Inc (Class A) | Andrew Paradise | Director, Chief Executive Officer, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.82 per share. | 23 Dec 2025 | 35,642 | 1,368,439 | - | 6.8 | 243,078 | Class A common stock |
| Skillz Inc (Class A) | Andrew Paradise | Director, Chief Executive Officer, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.00 per share. | 23 Dec 2025 | 35,642 | 1,332,797 | - | 8 | 285,136 | Class A common stock |
| Leap Therapeutics Inc | Thomas J. Dietz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. | 23 Dec 2025 | 35,000 | 48,000 (0%) | 0% | 1.2 | 42,000 | Common Stock |
| Exact Sciences Corp | Sarah Condella | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 34,018 | 140,883 (0%) | 0% | 0 | Common Stock | |
| Dynavax Tech Corp | John L. Slebir | SVP General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 33,750 | 71,328 (0%) | 0% | - | Common Stock | |
| Fathom Holdings Inc | Marco Fregenal | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Dec 2025 | 33,024 | 1,514,940 | - | 0 | Common Stock | |
| Dynavax Tech Corp | John L. Slebir | SVP General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.38 per share. | 23 Dec 2025 | 32,502 | 69,634 (0%) | 0% | 15.4 | 499,881 | Common Stock |
| Wayfair Inc (Class A) | Niraj Shah | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 101.31 per share. | 23 Dec 2025 | 32,096 | 473,953 (0%) | 0% | 101.3 | 3,251,646 | Class A Common Stock |
| Datavault AI Inc | Nathaniel Bradley | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.93 per share. | 23 Dec 2025 | 31,031 | 8,508,244 (34%) | 0% | 0.9 | 28,704 | Common Stock |
| Wayfair Inc (Class A) | Steven Conine | Director, Co-Founder | Sale of securities on an exchange or to another person at price $ 101.29 per share. | 23 Dec 2025 | 30,818 | 475,268 (0%) | 0% | 101.3 | 3,121,555 | Class A Common Stock |
| Exact Sciences Corp | James Herriott | SVP, General Counsel & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 30,287 | 74,024 (0%) | 0% | 0 | Common Stock | |
| Nano Nuclear Energy Inc | Kenny Yu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.00 per share. | 23 Dec 2025 | 30,177 | 45,177 | - | 3 | 90,531 | Common Stock |
| Nano Nuclear Energy Inc | Kenny Yu | Director | Sale of securities on an exchange or to another person at price $ 32.25 per share. | 23 Dec 2025 | 30,177 | 15,000 | - | 32.3 | 973,260 | Common Stock |
| Kingsway Fin Services Inc | John T. Fitzgerald | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 13.32 per share. | 23 Dec 2025 | 30,000 | 1,459,534 (6%) | 0% | 13.3 | 399,714 | Common Stock |
| Wayfair Inc (Class A) | Niraj Shah | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 102.32 per share. | 23 Dec 2025 | 30,000 | 439,137 (0%) | 0% | 102.3 | 3,069,600 | Class A Common Stock |
| Wayfair Inc (Class A) | Steven Conine | Director, Co-Founder | Sale of securities on an exchange or to another person at price $ 102.33 per share. | 23 Dec 2025 | 30,000 | 439,073 (0%) | 0% | 102.3 | 3,069,900 | Class A Common Stock |
| Dynavax Tech Corp | David Novack | President & COO | Sale of securities on an exchange or to another person at price $ 15.49 per share. | 23 Dec 2025 | 30,000 | 111,451 (0%) | 0% | 15.5 | 464,700 | Common Stock |
| Nano Nuclear Energy Inc | Tsun Yee Law | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 30,000 | 5,000 | - | - | Stock Options | |
| Exact Sciences Corp | Brian Baranick | EVP, GM, Precision Oncology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 29,416 | 118,812 (0%) | 0% | 0 | Common Stock | |
| Cintas | Scott D. Farmer | Director, Executive Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Dec 2025 | 29,000 | 595,392 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | Jacob Orville | EVP, GM, Screening | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 28,779 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp | Jacob Orville | EVP, GM, Screening | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 28,779 | 66,987 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | Brian Baranick | EVP, GM, Precision Oncology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 28,779 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp | Brian Baranick | EVP, GM, Precision Oncology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 28,779 | 65,050 (0%) | 0% | 0 | Common Stock | |
| NewAmsterdam Pharma Co NV | Louise Kooij | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 26,011 | 178,887 | - | - | Option (right to buy) | |
| NewAmsterdam Pharma Co NV | Louise Kooij | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 35.68 per share. | 23 Dec 2025 | 26,011 | 15,000 | - | 35.7 | 928,072 | Ordinary Shares |
| NewAmsterdam Pharma Co NV | Louise Kooij | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. | 23 Dec 2025 | 26,011 | 41,011 | - | 10 | 260,110 | Ordinary Shares |
| Cloudastructure Inc (Class A) | Richard Bentley | Ten Percent Owner, Founder | Sale of securities on an exchange or to another person at price $ 1.02 per share. | 23 Dec 2025 | 25,000 | 150,000 | - | 1.0 | 25,500 | Class A Common Stock |
| Cloudastructure Inc (Class A) | Richard Bentley | Ten Percent Owner, Founder | Sale of securities on an exchange or to another person at price $ 1.04 per share. | 23 Dec 2025 | 25,000 | 175,000 | - | 1.0 | 26,000 | Class A Common Stock |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 214.32 per share. | 23 Dec 2025 | 24,922 | 160,406 (0%) | 0% | 214.3 | 5,341,253 | Class A Common Stock |
| Broadcom | Hock E. Tan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 349.18 per share. | 23 Dec 2025 | 24,521 | 496,494 (0%) | 0% | 349.2 | 8,562,169 | Common Stock, $0.001 par value |
| Exact Sciences Corp | Aaron Bloomer | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 24,384 | 59,571 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | Aaron Bloomer | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 24,384 | 4,395 | - | - | Restricted Stock Units | |
| Wealthfront Corp | Julien Wetterwald | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 24,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Wealthfront Corp | Julien Wetterwald | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.45 per share. | 23 Dec 2025 | 24,000 | 529,835 | - | 2.5 | 58,800 | Common Stock |
| Safe Pro Grp Inc | Daniyel Erdberg | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Dec 2025 | 24,000 | 4,806,000 | - | 0 | Common Stock | |
| Exact Sciences Corp | Sarah Condella | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 23,817 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp | Sarah Condella | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 23,817 | 118,059 (0%) | 0% | 0 | Common Stock | |
| Skillz Inc (Class A) | Andrew Paradise | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 23,810 | 190,474 | - | - | Restricted Stock Units | |
| Skillz Inc (Class A) | Andrew Paradise | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 23,810 | 1,361,375 | - | 0 | Class A common stock | |
| Zions Bancorp N.A | Harris H. Simmons | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Dec 2025 | 23,031 | 1,277,029 (0%) | 0% | 0 | Common Stock | |
| Nano Nuclear Energy Inc | Tsun Yee Law | Director | Sale of securities on an exchange or to another person at price $ 32.26 per share. | 23 Dec 2025 | 22,691 | 100,000 | - | 32.3 | 731,925 | Common Stock |
| Nano Nuclear Energy Inc | Tsun Yee Law | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 23 Dec 2025 | 22,691 | 122,691 | - | 1.5 | 34,037 | Common Stock |
| Dynavax Tech Corp | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 22,620 | 92,663 (0%) | 0% | - | Common Stock | |
| Dynavax Tech Corp | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 22,620 | 22,620 | - | - | Restricted Stock Unit | |
| Korn Ferry | Robert P. Rozek | EVP, CFO & CCO | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Dec 2025 | 22,470 | 104,834 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Skillz Inc (Class A) | Andrew Paradise | Director, Chief Executive Officer, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.41 per share. | 23 Dec 2025 | 22,056 | 1,337,565 | - | 4.4 | 97,267 | Class A common stock |
| Lionsgate Studios Corp | Michael R. Burns | Vice Chair | Sale of securities on an exchange or to another person at price $ 9.01 per share. | 23 Dec 2025 | 21,748 | 3,061,213 | - | 9.0 | 195,949 | Common Shares |
| Exact Sciences Corp | Brian Baranick | EVP, GM, Precision Oncology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. | 23 Dec 2025 | 21,594 | 79,265 (0%) | 0% | 101.8 | 2,198,701 | Common Stock |
| Principal Financial Group | Deanna D. Strable-Soethout | President and CEO | Sale or transfer of securities back to the company at price $ 90.05 per share. | 23 Dec 2025 | 20,715 | 153,468 (0%) | 0% | 90.1 | 1,865,386 | Common Stock |
| Principal Financial Group | Deanna D. Strable-Soethout | President and CEO | Grant, award, or other acquisition of securities at price $ 37.38 per share. | 23 Dec 2025 | 20,715 | 174,183 (0%) | 0% | 37.4 | 774,327 | Common Stock |
| Exact Sciences Corp | Jacob Orville | EVP, GM, Screening | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 20,584 | 105,088 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | Brian Baranick | EVP, GM, Precision Oncology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 20,584 | 99,849 (0%) | 0% | 0 | Common Stock | |
| Aeluma Inc | Mark N. Tompkins | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 18.01 per share. | 23 Dec 2025 | 20,368 | 2,027,650 | - | 18.0 | 366,828 | Common Stock |
| Broadcom | Hock E. Tan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 348.38 per share. | 23 Dec 2025 | 20,288 | 521,015 (0%) | 0% | 348.4 | 7,067,933 | Common Stock, $0.001 par value |
| Dynavax Tech Corp | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.80 per share. | 23 Dec 2025 | 20,000 | 131,451 (0%) | 0% | 6.8 | 136,100 | Common Stock |
| Dynavax Tech Corp | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 20,000 | 166,528 | - | - | Stock Option (Right to Buy) | |
| Perpetua Resources Corp | Robert Dean | Director | 23 Dec 2025 | 20,000 | 0 | - | - | Director and Employee Stock Option (right to buy) | ||
| Perpetua Resources Corp | Robert Dean | Director | 23 Dec 2025 | 20,000 | 30,000 | - | 8.6 | 171,200 | Common Shares | |
| Rocket Lab USA Inc | Alexander R. Slusky | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Dec 2025 | 20,000 | 68,849 | - | 0 | Common Stock | |
| Nano Nuclear Energy Inc | Diane Hare | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 20,000 | 25,000 | - | - | Stock Options | |
| Exact Sciences Corp | Jacob Orville | EVP, GM, Screening | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. | 23 Dec 2025 | 19,986 | 84,504 (0%) | 0% | 101.8 | 2,034,975 | Common Stock |
| Wayfair Inc (Class A) | Niraj Shah | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 99.28 per share. | 23 Dec 2025 | 19,904 | 564,697 (0%) | 0% | 99.3 | 1,976,069 | Class A Common Stock |
| Skillz Inc (Class A) | Gaetano Franceschi | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 19,048 | 111,718 | - | 0 | Class A common stock | |
| Skillz Inc (Class A) | Gaetano Franceschi | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 19,048 | 0 | - | - | Restricted Stock Unit | |
| Grid Dynamics Holdings Inc (Class A) | Eric A. Benhamou | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 19,021 | 100,898 | - | 0 | Common Stock | |
| Grid Dynamics Holdings Inc (Class A) | Lloyd A. Carney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 19,021 | 689,977 | - | 0 | Common Stock | |
| Dynavax Tech Corp | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 18,788 | 111,451 (0%) | 0% | - | Common Stock | |
| Dynavax Tech Corp | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 18,788 | 37,576 | - | - | Restricted Stock Unit | |
| Wayfair Inc (Class A) | Steven Conine | Director, Co-Founder | Sale of securities on an exchange or to another person at price $ 99.26 per share. | 23 Dec 2025 | 18,753 | 565,766 (0%) | 0% | 99.3 | 1,861,423 | Class A Common Stock |
| Nano Nuclear Energy Inc | Tsun Yee Law | Director | Sale of securities on an exchange or to another person at price $ 32.25 per share. | 23 Dec 2025 | 18,670 | 81,330 | - | 32.2 | 602,065 | Common Stock |
| Duluth Holdings Inc (Class B) | Richard W. Schlecht | SVP, Product Dev. & Sourcing | Purchase of securities on an exchange or from another person at price $ 2.17 per share. | 23 Dec 2025 | 18,052 | 341,731 (1%) | 0% | 2.2 | 39,084 | Class B Common Stock |
| Royal Caribbean Cruises | Richard D. Fain | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Dec 2025 | 17,552 | 52,695 (0%) | 0% | 0 | Common Stock | |
| Rivian Automotive Inc (Class A) | Robert J. Scaringe | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 21.43 per share. | 23 Dec 2025 | 17,450 | 1,150,109 | - | 21.4 | 373,871 | Class A Common Stock |
| Village Farms Intl Inc | John R. McLernon | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.61 per share. | 23 Dec 2025 | 17,168 | 130,642 (0%) | 0% | 3.6 | 61,976 | Common Shares |
| Village Farms Intl Inc | John Henry | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.61 per share. | 23 Dec 2025 | 17,168 | 168,142 (0%) | 0% | 3.6 | 61,976 | Common Shares |
| Village Farms Intl Inc | Christopher Woodward | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.61 per share. | 23 Dec 2025 | 17,163 | 174,727 (0%) | 0% | 3.6 | 61,958 | Common Shares |
| Exact Sciences Corp | Aaron Bloomer | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. | 23 Dec 2025 | 17,151 | 35,187 (0%) | 0% | 101.8 | 1,746,315 | Common Stock |
| Exact Sciences Corp | James Herriott | SVP, General Counsel & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 17,009 | 46,496 (0%) | 0% | 0 | Common Stock | |
| Dynavax Tech Corp | John L. Slebir | SVP General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 16,667 | 16,667 | - | - | Restricted Stock Unit | |
| Dynavax Tech Corp | John L. Slebir | SVP General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 16,667 | 87,995 (0%) | 0% | - | Common Stock | |
| Lifeway Foods Inc | Ludmila Smolyansky | Member of 10% owner group | Sale of securities on an exchange or to another person at price $ 23.97 per share. | 23 Dec 2025 | 16,431 | 767,823 (4%) | 0% | 24.0 | 393,851 | Common Stock, no par value |
| Exact Sciences Corp | Jacob Orville | EVP, GM, Screening | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 16,051 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp | Jacob Orville | EVP, GM, Screening | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 16,051 | 69,511 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | Brian Baranick | EVP, GM, Precision Oncology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 16,051 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp | Brian Baranick | EVP, GM, Precision Oncology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 16,051 | 66,487 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | Sarah Condella | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. | 23 Dec 2025 | 15,989 | 124,894 (0%) | 0% | 101.8 | 1,628,000 | Common Stock |
| Skillz Inc (Class A) | Gaetano Franceschi | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.61 per share. | 23 Dec 2025 | 15,915 | 106,586 | - | 5.6 | 89,283 | Class A common stock |
| Dynavax Tech Corp | Kelly MacDonald | SVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 15,477 | 82,204 (0%) | 0% | - | Common Stock | |
| Dynavax Tech Corp | Kelly MacDonald | SVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 15,477 | 15,477 | - | - | Restricted Stock Unit | |
| Exact Sciences Corp | James Herriott | SVP, General Counsel & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 15,144 | 74,933 (0%) | 0% | 0 | Common Stock | |
| Aeluma Inc | Mark N. Tompkins | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 14.87 per share. | 23 Dec 2025 | 15,000 | 2,069,988 | - | 14.9 | 223,050 | Common Stock |
| Aeluma Inc | Mark N. Tompkins | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.05 per share. | 23 Dec 2025 | 15,000 | 2,054,988 | - | 16.1 | 240,750 | Common Stock |
| Exact Sciences Corp | Brian Baranick | EVP, GM, Precision Oncology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.59 per share. | 23 Dec 2025 | 14,938 | 103,874 (0%) | 0% | 101.6 | 1,517,551 | Common Stock |
| Butterfly Network Inc (Class A) | Jonathan M. Rothberg | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.01 per share. | 23 Dec 2025 | 14,911 | 1,140,180 | - | 4.0 | 59,790 | Class A Common Stock |
| Home Bancshares Inc | John W. Allison | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Dec 2025 | 14,850 | 5,495,926 (3%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | Jacob Orville | EVP, GM, Screening | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 14,845 | 45,186 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | Jacob Orville | EVP, GM, Screening | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 14,845 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp | Brian Baranick | EVP, GM, Precision Oncology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 14,845 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp | Brian Baranick | EVP, GM, Precision Oncology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 14,845 | 43,810 (0%) | 0% | 0 | Common Stock | |
| Datavault AI Inc | Stanley Mbugua | See Remarks | Sale of securities on an exchange or to another person at price $ 0.92 per share. | 23 Dec 2025 | 14,720 | 1,066,291 (4%) | 0% | 0.9 | 13,616 | Common Stock |
| Nano Nuclear Energy Inc | Diane Hare | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.00 per share. | 23 Dec 2025 | 14,640 | 14,640 | - | 3 | 43,920 | Common Stock |
| Nano Nuclear Energy Inc | Diane Hare | Director | Sale of securities on an exchange or to another person at price $ 32.24 per share. | 23 Dec 2025 | 14,640 | 0 | - | 32.2 | 471,986 | Common Stock |
| Exact Sciences Corp | Brian Baranick | EVP, GM, Precision Oncology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. | 23 Dec 2025 | 14,614 | 50,436 (0%) | 0% | 101.8 | 1,487,997 | Common Stock |
| Exact Sciences Corp | James Herriott | SVP, General Counsel & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. | 23 Dec 2025 | 14,235 | 59,789 (0%) | 0% | 101.8 | 1,449,408 | Common Stock |
| Dynavax Tech Corp | John L. Slebir | SVP General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 14,141 | 28,282 | - | - | Restricted Stock Unit | |
| Dynavax Tech Corp | John L. Slebir | SVP General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 14,141 | 102,136 (0%) | 0% | - | Common Stock | |
| Dynavax Tech Corp | Kelly MacDonald | SVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 14,141 | 96,345 (0%) | 0% | - | Common Stock | |
| Dynavax Tech Corp | Kelly MacDonald | SVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 14,141 | 28,282 | - | - | Restricted Stock Unit | |
| Cintas | Robert E. Coletti | Director, Assistant Secretary | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Dec 2025 | 14,000 | 19,400 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | James Herriott | SVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 13,893 | 32,934 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | James Herriott | SVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 13,893 | 0 | - | - | Restricted Stock Units | |
| Leslies Inc | Jeff White | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 13,875 | 35,625 | - | - | Restricted Stock Units | |
| Leslies Inc | Jeff White | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 13,875 | 13,875 | - | - | Options to purchase shares | |
| Principal Financial Group | Deanna D. Strable-Soethout | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 13,592 | 0 | - | - | Common Stock | |
| Exact Sciences Corp | Jacob Orville | EVP, GM, Screening | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. | 23 Dec 2025 | 13,527 | 53,460 (0%) | 0% | 101.8 | 1,377,319 | Common Stock |
| Dynavax Tech Corp | Joseph Anthony Metzinger | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 12,727 | 12,727 (0%) | 0% | - | Common Stock | |
| Dynavax Tech Corp | Joseph Anthony Metzinger | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 12,727 | 25,455 | - | - | Restricted Stock Unit | |
| Altimmune Inc | John M. Gill | Director | Purchase of securities on an exchange or from another person at price $ 4.10 per share. | 23 Dec 2025 | 12,500 | 12,500 (0%) | 0% | 4.1 | 51,250 | Common Stock, par value $0.0001 |
| Applied Optoelectronics Inc | David C. Kuo | *** See Remarks | Sale of securities on an exchange or to another person at price $ 40.15 per share. | 23 Dec 2025 | 12,500 | 130,948 (0%) | 0% | 40.2 | 501,875 | Common Stock, $.001 par value |
| Grid Dynamics Holdings Inc (Class A) | Michael Southworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 12,500 | 48,810 | - | 0 | Common Stock | |
| Datavault AI Inc | Nathaniel Bradley | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.93 per share. | 23 Dec 2025 | 11,987 | 4,492,957 (18%) | 0% | 0.9 | 11,088 | Common Stock |
| Fluor Corp | David E. Constable | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.90 per share. | 23 Dec 2025 | 11,889 | 780,138 (0%) | 0% | 40.9 | 486,260 | Common Stock |
| Exact Sciences Corp | Sarah Condella | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 11,876 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp | Sarah Condella | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 11,876 | 99,824 (0%) | 0% | 0 | Common Stock | |
| Grid Dynamics Holdings Inc (Class A) | Marina Levinson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 11,413 | 44,903 | - | 0 | Common Stock | |
| Grid Dynamics Holdings Inc (Class A) | Shuo Zhang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 11,413 | 103,928 | - | 0 | Common Stock | |
| Solo Brands Inc (Class A) | John P. Larson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 11,201 | 112,012 | - | - | Restricted Stock Unit | |
| Solo Brands Inc (Class A) | John P. Larson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 11,201 | 77,663 | - | 0 | Class A Common Stock | |
| Exact Sciences Corp | Sarah Condella | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. | 23 Dec 2025 | 11,194 | 106,865 (0%) | 0% | 101.8 | 1,139,773 | Common Stock |
| AnaptysBio Inc | John Schmid | Director | Other type of transaction at price $ 51.00 per share. | 23 Dec 2025 | 11,068 | 0 (0%) | 0% | 51 | 564,468 | Common Stock |
| Broadcom | Hock E. Tan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 341.17 per share. | 23 Dec 2025 | 11,005 | 575,556 (0%) | 0% | 341.2 | 3,754,565 | Common Stock, $0.001 par value |
| Exact Sciences Corp | Aaron Bloomer | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. | 23 Dec 2025 | 10,803 | 48,768 (0%) | 0% | 101.8 | 1,099,961 | Common Stock |
| Broadcom | Hock E. Tan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 342.00 per share. | 23 Dec 2025 | 10,612 | 564,944 (0%) | 0% | 342.0 | 3,629,283 | Common Stock, $0.001 par value |
| Duluth Holdings Inc (Class B) | Richard W. Schlecht | SVP, Product Dev. & Sourcing | Purchase of securities on an exchange or from another person at price $ 2.22 per share. | 23 Dec 2025 | 10,502 | 352,233 (1%) | 0% | 2.2 | 23,309 | Class B Common Stock |
| Exact Sciences Corp | Brian Baranick | EVP, GM, Precision Oncology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. | 23 Dec 2025 | 10,453 | 89,396 (0%) | 0% | 101.8 | 1,064,324 | Common Stock |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 76.53 per share. | 23 Dec 2025 | 10,042 | 17,793,890 (18%) | 0% | 76.5 | 768,474 | Common Shares |
| Jabil | Steven D. Borges | EVP, Global Business Units | Sale of securities on an exchange or to another person at price $ 235.00 per share. | 23 Dec 2025 | 10,000 | 90,524 (0%) | 0% | 235 | 2,350,000 | Common Stock |
| Lifeway Foods Inc | Ludmila Smolyansky | Member of 10% owner group | Sale of securities on an exchange or to another person at price $ 25.15 per share. | 23 Dec 2025 | 10,000 | 757,823 (4%) | 0% | 25.2 | 251,500 | Common Stock, no par value |
| Dynavax Tech Corp | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.47 per share. | 23 Dec 2025 | 10,000 | 141,451 (0%) | 0% | 10.5 | 104,700 | Common Stock |
| Dynavax Tech Corp | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 10,000 | 85,655 | - | - | Stock Option (Right to Buy) | |
| Verrica Pharma Inc | John J. Kirby | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 10,000 | 18,962 (0%) | 0% | 0 | Common Stock | |
| Grid Dynamics Holdings Inc (Class A) | Leonard Livschitz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 9.33 per share. | 23 Dec 2025 | 10,000 | 2,821,378 | - | 9.3 | 93,300 | Common Stock |
| Natural Alternatives Intl Inc | Mark A. LeDoux | Director, CEO/Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Dec 2025 | 10,000 | 150,221 (2%) | 0% | - | Common Stock | |
| Cullinan Oncology Inc | Nadim Ahmed | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.01 per share. | 23 Dec 2025 | 9,922 | 420,699 | - | 10.0 | 99,319 | Common Stock |
| Exact Sciences Corp | James Herriott | SVP, General Counsel & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 9,880 | 48,381 (0%) | 0% | 0 | Common Stock | |
| Nano Nuclear Energy Inc | Kenny Yu | Director | Sale of securities on an exchange or to another person at price $ 32.98 per share. | 23 Dec 2025 | 9,823 | 15,000 | - | 33.0 | 323,947 | Common Stock |
| Nano Nuclear Energy Inc | Kenny Yu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.00 per share. | 23 Dec 2025 | 9,823 | 24,823 | - | 3 | 29,469 | Common Stock |
| Exact Sciences Corp | Jacob Orville | EVP, GM, Screening | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. | 23 Dec 2025 | 9,675 | 95,413 (0%) | 0% | 101.8 | 985,109 | Common Stock |
| SoFi Tech Inc | Kelli Keough | EVP, GBUL, SIPS | Sale of securities on an exchange or to another person at price $ 27.14 per share. | 23 Dec 2025 | 9,468 | 312,948 | - | 27.1 | 256,948 | Common Stock |
| Exact Sciences Corp | Jacob Orville | EVP, GM, Screening | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 9,450 | 34,783 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | Jacob Orville | EVP, GM, Screening | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 9,450 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp | Brian Baranick | EVP, GM, Precision Oncology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 9,450 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp | Brian Baranick | EVP, GM, Precision Oncology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 9,450 | 33,764 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | Jacob Orville | EVP, GM, Screening | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 9,416 | 104,829 (0%) | 0% | 0 | Common Stock | |
| Skillz Inc (Class A) | Andrew Paradise | Director, Chief Executive Officer, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.82 per share. | 23 Dec 2025 | 9,370 | 1,278,415 | - | 6.8 | 63,903 | Class A common stock |
| Skillz Inc (Class A) | Andrew Paradise | Director, Chief Executive Officer, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.50 per share. | 23 Dec 2025 | 9,370 | 1,287,785 | - | 4.5 | 42,165 | Class A common stock |
| Skillz Inc (Class A) | Andrew Paradise | Director, Chief Executive Officer, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.00 per share. | 23 Dec 2025 | 9,370 | 1,269,045 | - | 8 | 74,960 | Class A common stock |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 77.63 per share. | 23 Dec 2025 | 9,265 | 17,805,334 (18%) | 0% | 77.6 | 719,251 | Common Shares |
| Grid Dynamics Holdings Inc (Class A) | Lloyd A. Carney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 9,239 | 699,216 | - | 0 | Common Stock | |
| Leslies Inc | Amy College | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 8,914 | 8,914 | - | - | Option to purchase shares | |
| Leslies Inc | Amy College | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 8,914 | 24,198 | - | - | Restricted Stock Units | |
| Leslies Inc | Naomi Cramer | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 8,914 | 32,865 | - | - | Restricted Stock Units | |
| Leslies Inc | Naomi Cramer | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 8,914 | 8,914 | - | - | Options to purchase shares | |
| Urban Outfitters Inc | Margaret A. Hayne | Director, Co-President & CCO | Sale of securities on an exchange or to another person at price $ 76.53 per share. | 23 Dec 2025 | 8,787 | 2,235,275 (2%) | 0% | 76.5 | 672,434 | Common Shares |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 76.53 per share. | 23 Dec 2025 | 8,787 | 2,235,275 (2%) | 0% | 76.5 | 672,434 | Common Shares |
| Grid Dynamics Holdings Inc (Class A) | Eric A. Benhamou | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 8,695 | 109,593 | - | 0 | Common Stock | |
| Vicor Corp | Patrizio Vinciarelli | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 108.41 per share. | 23 Dec 2025 | 8,640 | 9,768,363 (33%) | 0% | 108.4 | 936,655 | Common Stock |
| TherapeuticsMD Inc | Tommy G. Thompson | Director | Purchase of securities on an exchange or from another person at price $ 1.67 per share. | 23 Dec 2025 | 8,400 | 23,179 (0%) | 0% | 1.7 | 14,031 | Common Stock |
| Paychex | Martin Mucci | Director, Chairman | Gift of securities by or to the insider at price $ 114.36 per share. | 23 Dec 2025 | 8,277 | 418,047 (0%) | 0% | 114.4 | 946,558 | Common Stock |
| Vicor Corp | Patrizio Vinciarelli | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 107.61 per share. | 23 Dec 2025 | 8,276 | 9,777,003 (33%) | 0% | 107.6 | 890,555 | Common Stock |
| Sutro Biopharma Inc | Gregory K. Chow | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 8,200 | 8,200 | - | - | Stock Option (right to buy) | |
| Grid Dynamics Holdings Inc (Class A) | Weihang Wang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 8,152 | 42,778 | - | 0 | Common Stock | |
| Grid Dynamics Holdings Inc (Class A) | Yueou Wang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 8,152 | 42,778 | - | 0 | Common Stock | |
| Grid Dynamics Holdings Inc (Class A) | Patrick Nicolet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 8,152 | 28,484 | - | 0 | Common Stock | |
| Exact Sciences Corp | Brian Baranick | EVP, GM, Precision Oncology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. | 23 Dec 2025 | 8,151 | 58,336 (0%) | 0% | 101.8 | 829,935 | Common Stock |
| Urban Outfitters Inc | Margaret A. Hayne | Director, Co-President & CCO | Sale of securities on an exchange or to another person at price $ 77.63 per share. | 23 Dec 2025 | 8,107 | 2,245,288 (2%) | 0% | 77.6 | 629,355 | Common Shares |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 77.63 per share. | 23 Dec 2025 | 8,107 | 2,245,288 (2%) | 0% | 77.6 | 629,355 | Common Shares |
| Amylyx Pharma Inc | Karen Firestone | Director | Purchase of securities on an exchange or from another person at price $ 12.45 per share. | 23 Dec 2025 | 8,100 | 63,100 | - | 12.5 | 100,845 | Common Stock |
| Exact Sciences Corp | Sarah Condella | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 8,000 | 132,894 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | James Herriott | SVP, General Counsel & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. | 23 Dec 2025 | 7,995 | 38,501 (0%) | 0% | 101.8 | 814,051 | Common Stock |
| Sutro Biopharma Inc | Hans-Peter Gerber | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 7,925 | 7,925 | - | - | Stock Option (right to buy) | |
| Dermata Therapeutics Inc | Kyri K. Van Hoose | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 7,874 | 7,874 | - | - | Warrant (Right to Buy) | |
| Dermata Therapeutics Inc | Kyri K. Van Hoose | SVP, CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Dec 2025 | 7,874 | 0 | - | - | Warrant (Right to Buy) | |
| Enveric Biosciences Inc | Marcus Schabacker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 7,633 | 7,900 (0%) | 0% | 0 | Common Stock | |
| Enveric Biosciences Inc | George Kegler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 7,633 | 7,900 (0%) | 0% | 0 | Common Stock | |
| Enveric Biosciences Inc | Sheila DeWitt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 7,633 | 7,788 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | Sarah Condella | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 7,560 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp | Sarah Condella | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 7,560 | 91,502 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | Jacob Orville | EVP, GM, Screening | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. | 23 Dec 2025 | 7,544 | 61,967 (0%) | 0% | 101.8 | 768,130 | Common Stock |
| Exact Sciences Corp | Brian Baranick | EVP, GM, Precision Oncology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. | 23 Dec 2025 | 7,539 | 36,271 (0%) | 0% | 101.8 | 767,621 | Common Stock |
| Exact Sciences Corp | James Herriott | SVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 7,334 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp | James Herriott | SVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 7,334 | 32,934 (0%) | 0% | 0 | Common Stock | |
| Nano Nuclear Energy Inc | Tsun Yee Law | Director | Sale of securities on an exchange or to another person at price $ 32.98 per share. | 23 Dec 2025 | 7,309 | 100,000 | - | 33.0 | 241,080 | Common Stock |
| Nano Nuclear Energy Inc | Tsun Yee Law | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 23 Dec 2025 | 7,309 | 107,309 | - | 1.5 | 10,964 | Common Stock |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 7,200 | 7,200 | - | - | Stock Option (right to buy) | |
| Exact Sciences Corp | James Herriott | SVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 7,125 | 21,586 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | James Herriott | SVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 7,125 | 0 | - | - | Restricted Stock Units | |
| Principal Financial Group | Deanna D. Strable-Soethout | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 7,123 | 15,557 | - | - | Common Stock | |
| Exact Sciences Corp | James Herriott | SVP, General Counsel & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. | 23 Dec 2025 | 7,118 | 67,815 (0%) | 0% | 101.8 | 724,755 | Common Stock |
| WhiteHorse Finance Inc | John Bolduc | Director | Purchase of securities on an exchange or from another person at price $ 7.00 per share. | 23 Dec 2025 | 7,100 | 255,930 (1%) | 0% | 7 | 49,700 | Common Stock, par value $0.001 per share |
| WhiteHorse Finance Inc | John Bolduc | Director | Purchase of securities on an exchange or from another person at price $ 6.99 per share. | 23 Dec 2025 | 7,100 | 259,085 (1%) | 0% | 7.0 | 49,629 | Common Stock, par value $0.001 per share |
| Exact Sciences Corp | Jacob Orville | EVP, GM, Screening | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. | 23 Dec 2025 | 6,978 | 38,208 (0%) | 0% | 101.8 | 710,500 | Common Stock |
| Aeluma Inc | Mark N. Tompkins | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.91 per share. | 23 Dec 2025 | 6,970 | 2,048,018 | - | 16.9 | 117,863 | Common Stock |
| Clene Inc | Chidozie Ugwumba | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.27 per share. | 23 Dec 2025 | 6,831 | 800,664 | - | 6.3 | 42,830 | Common Stock |
| Vaxcyte Inc | Elvia Cowan | SVP, FINANCE | Sale of securities on an exchange or to another person at price $ 47.93 per share. | 23 Dec 2025 | 6,716 | 14,534 | - | 47.9 | 321,931 | Common Stock |
| Exact Sciences Corp | James Herriott | SVP, General Counsel & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. | 23 Dec 2025 | 6,530 | 25,600 (0%) | 0% | 101.8 | 664,885 | Common Stock |
| Grid Dynamics Holdings Inc (Class A) | Michael Southworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 6,521 | 55,331 | - | 0 | Common Stock | |
| Jabil | Steven A. Raymund | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Dec 2025 | 6,500 | 67,496 (0%) | 0% | 0 | Common Stock | |
| Perpetua Resources Corp | Robert Dean | Director | Sale of securities on an exchange or to another person at price $ 27.55 per share. | 23 Dec 2025 | 6,490 | 23,510 | - | 27.6 | 178,800 | Common Shares |
| Nano Nuclear Energy Inc | Tsun Yee Law | Director | Sale of securities on an exchange or to another person at price $ 32.98 per share. | 23 Dec 2025 | 6,330 | 75,000 | - | 33.0 | 208,743 | Common Stock |
| MeiraGTx Holdings PLC | Alexandria Forbes | Director, PRESIDENT & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Dec 2025 | 6,250 | 1,307,733 (3%) | 0% | 0 | Ordinary Shares | |
| Wayfair Inc (Class A) | Steven Conine | Director, Co-Founder | Sale of securities on an exchange or to another person at price $ 101.63 per share. | 23 Dec 2025 | 6,195 | 469,073 (0%) | 0% | 101.6 | 629,598 | Class A Common Stock |
| BP PLC (ADR) | Katherine Anne Thomson | Executive Director,Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.27 per share. | 23 Dec 2025 | 6,103 | 427,646 (0%) | 0% | 4.3 | 26,078 | Ords 0.25p |
| Lovesac Co | Shawn D. Nelson | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Dec 2025 | 6,050 | 169,060 (1%) | 0% | 0 | Common Stock, $0.00001 par value | |
| Broadcom | Hock E. Tan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 344.18 per share. | 23 Dec 2025 | 6,016 | 556,673 (0%) | 0% | 344.2 | 2,070,557 | Common Stock, $0.001 par value |
| Leslies Inc | Benjamin Lindquist | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 6,010 | 8,627 | - | - | Restricted Stock Units | |
| Leslies Inc | Benjamin Lindquist | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 6,010 | 6,010 | - | - | Options to purchase shares | |
| Hyatt Hotels Corp (Class A) | Javier Aguila | See Remarks | Sale of securities on an exchange or to another person at price $ 165.88 per share. | 23 Dec 2025 | 6,000 | 2,684 (0%) | 0% | 165.9 | 995,280 | Class A Common Stock |
| Oil-Dri Corp Of America | Michael A. Nemeroff | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Dec 2025 | 5,987 | 52,815 (0%) | 0% | 0 | Common Stock | |
| Grid Dynamics Holdings Inc (Class A) | Marina Levinson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 5,978 | 50,881 | - | 0 | Common Stock | |
| Grid Dynamics Holdings Inc (Class A) | Shuo Zhang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 5,978 | 109,906 | - | 0 | Common Stock | |
| Skillz Inc (Class A) | Andrew Paradise | Director, Chief Executive Officer, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.41 per share. | 23 Dec 2025 | 5,798 | 1,355,577 | - | 4.4 | 25,569 | Class A common stock |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 77.62 per share. | 23 Dec 2025 | 5,642 | 17,819,624 (18%) | 0% | 77.6 | 437,949 | Common Shares |
| Dynavax Tech Corp | Joseph Anthony Metzinger | VP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.38 per share. | 23 Dec 2025 | 5,598 | 7,129 (0%) | 0% | 15.4 | 86,097 | Common Stock |
| Exact Sciences Corp | Sarah Condella | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. | 23 Dec 2025 | 5,582 | 94,242 (0%) | 0% | 101.8 | 568,359 | Common Stock |
| Hyatt Hotels Corp (Class A) | Javier Aguila | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 5,580 | 1,860 | - | - | Stock Appreciation Rights | |
| Hyatt Hotels Corp (Class A) | Javier Aguila | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.96 per share. | 23 Dec 2025 | 5,580 | 8,264 (0%) | 0% | 89.0 | 496,397 | Class A Common Stock |
| Galectin Therapeutics Inc | Kevin D. Freeman | Director | Purchase of securities on an exchange or from another person at price $ 3.55 per share. | 23 Dec 2025 | 5,500 | 55,269 (0%) | 0% | 3.5 | 19,514 | Common Stock |
| Galectin Therapeutics Inc | Kevin D. Freeman | Director | Purchase of securities on an exchange or from another person at price $ 3.55 per share. | 23 Dec 2025 | 5,500 | 55,269 (0%) | 0% | 3.5 | 19,514 | Common Stock |
| Broadcom | Hock E. Tan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 345.24 per share. | 23 Dec 2025 | 5,426 | 551,247 (0%) | 0% | 345.2 | 1,873,251 | Common Stock, $0.001 par value |
| Host Hotels & Resorts - REIT | Mary L. Baglivo | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Dec 2025 | 5,400 | 16,430 (0%) | 0% | 0 | Common Stock | |
| Nano Nuclear Energy Inc | Diane Hare | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.00 per share. | 23 Dec 2025 | 5,360 | 5,360 | - | 3 | 16,080 | Common Stock |
| Nano Nuclear Energy Inc | Diane Hare | Director | Sale of securities on an exchange or to another person at price $ 32.96 per share. | 23 Dec 2025 | 5,360 | 0 | - | 33.0 | 176,655 | Common Stock |
| Broadcom | Hock E. Tan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 347.39 per share. | 23 Dec 2025 | 5,329 | 541,303 (0%) | 0% | 347.4 | 1,851,241 | Common Stock, $0.001 par value |
| Phio Pharma Corp | Robert J. Bitterman | Director, Chairman, Pres. & CEO | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 23 Dec 2025 | 5,000 | 286,421 (15%) | 0% | 1.0 | 5,100 | Common Stock, $.0001 par value |
| Howard Hughes Holdings Inc | R. Sellers | Director | Purchase of securities on an exchange or from another person at price $ 77.94 per share. | 23 Dec 2025 | 5,000 | 67,517 (0%) | 0% | 77.9 | 389,713 | Common stock, $0.01 par value |
| Accel Entertainment Inc (Class A1) | Derek Harmer | Chief Compliance Officer | Sale of securities on an exchange or to another person at price $ 11.50 per share. | 23 Dec 2025 | 5,000 | 199,917 (11%) | 0% | 11.5 | 57,500 | Class A-1 Common Stock |
| Accel Entertainment Inc (Class A1) | Derek Harmer | Chief Compliance Officer | Sale of securities on an exchange or to another person at price $ 11.50 per share. | 23 Dec 2025 | 5,000 | 194,917 (11%) | 0% | 11.5 | 57,500 | Class A-1 Common Stock |
| Quest Resource Holding Corp | Glenn A. Culpepper | Director | Purchase of securities on an exchange or from another person at price $ 1.96 per share. | 23 Dec 2025 | 5,000 | 56,585 (0%) | 0% | 2.0 | 9,800 | Common Stock |
| Perpetua Resources Corp | Robert Dean | Director | Sale of securities on an exchange or to another person at price $ 26.31 per share. | 23 Dec 2025 | 5,000 | 18,510 | - | 26.3 | 131,550 | Common Shares |
| Palo Alto | Dipak Golechha | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 188.18 per share. | 23 Dec 2025 | 5,000 | 155,119 (0%) | 0% | 188.2 | 940,910 | Common Stock |
| NewAmsterdam Pharma Co NV | Louise Kooij | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 5,000 | 218,134 | - | - | Option (right to buy) | |
| NewAmsterdam Pharma Co NV | Louise Kooij | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.90 per share. | 23 Dec 2025 | 5,000 | 58,872 | - | 10.9 | 54,500 | Ordinary Shares |
| Rocket Lab USA Inc | Edward H. Frank | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Dec 2025 | 5,000 | 145,004 | - | 0 | Common Stock | |
| Urban Outfitters Inc | Margaret A. Hayne | Director, Co-President & CCO | Sale of securities on an exchange or to another person at price $ 77.62 per share. | 23 Dec 2025 | 4,937 | 2,257,791 (2%) | 0% | 77.6 | 383,225 | Common Shares |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 77.62 per share. | 23 Dec 2025 | 4,937 | 2,257,791 (2%) | 0% | 77.6 | 383,225 | Common Shares |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.